Man­u­fac­tur­ing roundup: GSK opens a new fa­cil­i­ty at Barnard Cas­tle lo­ca­tion; Tenaya Ther­a­peu­tics com­pletes build­out of Bay Area ge­net­ic med­i­cine man­u­fac­tur­ing site

GSK is con­tin­u­ing to build out its Barnard Cas­tle site in the UK.

Ac­cord­ing to the com­pa­ny, it has opened a new asep­tic smart man­u­fac­tur­ing fa­cil­i­ty at the site, which is lo­cat­ed in Coun­ty Durham in the north­east of Eng­land.

The new fa­cil­i­ty, known as Q Block, is a ful­ly au­to­mat­ed and dig­i­tal fa­cil­i­ty that lever­ages dig­i­tal tech­nol­o­gy to make man­u­fac­tur­ing op­er­a­tions as ef­fi­cient as pos­si­ble.

The 11,500-square-me­ter fa­cil­i­ty start­ed con­struc­tion in 2018 and ac­cord­ing to the UK news site Busi­ness Live, the costs for the new build­ing were £90 mil­lion, or around $110 mil­lion.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN